Skip to main content
Caplight Logo









DigiFluidic Bio-Technology

DigiFluidic Bio-Technology

Private
SingaporeHealthcare & Life Scienceshttps://digifluidic.com/

Last Round

Series A

Extension

Sep 29, 2022

Total Funding Raised

$15.45M

Company Overview

DigiFluidic Bio-Technology is a biotechnology company that develops a fully automated, programmable digital fluidic platform for a wide range of life science applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

digital microfluidicsnucleic acid analysispoint-of-care testingPOCTlab-on-a-chiprapid diagnosticsmolecular diagnosticsmicrofluidic chipsportable diagnosticsin vitro diagnosticsbiotech equipmentfood safety testinganimal disease detectionrazor and blade modelODM/OEM services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DigiFluidic Bio-Technology Comparables

Compare DigiFluidic Bio-Technology with similar companies based on industry and business-model similarity.

DigiFluidic Bio-Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prompt Diagnostics
81%
FluxErgy
79%
Genetic Microdevices Limited
78%

DigiFluidic Bio-Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 29, 2022

DigiFluidic Bio-Technology Investors

Notable investors and investment history

DigiFluidic Bio-Technology investors
InvestorRounds
ConvergenceSeries A Extension
Guangzhou Huiju Capital Equity Investment Management Co., Ltd.Series A Extension
Guangzhou Qudao Asset ManagementSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 40% MoM.

  • Apr 1, 2026

    Monthly visitors increased 56% MoM, reaching 1.4K.

DigiFluidic Bio-Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DigiFluidic Bio-Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DigiFluidic Bio-Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range2
Year Founded2021
Last FundingSep 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?